Welcome to NVM
NVM is one of the UK’s leading independent private equity businesses focussed on making equity investments of between £2 million and £10 million in UK unquoted companies.
NVM manages £175 million of funds and is differentiated by having executives living and working in regional business communities throughout the UK.
Latest news
Northern 3 VCT launches
new share issue
Northern 3 VCT PLC has launched a public offer of 15 million new ordinary shares. An “early bird” incentive is in place until 26 February 2010. For further information & the prospectus click here.
Abermed sold to
International SOS
NVM has sold DxS to Qiagen to create a global leader in personalised medicine for a value of $130 million ($95 million initial consideration plus earnouts of up to $35 million). For further information click here.
DxS sold to Qiagen –
record exit for NVM
NVM has sold DxS to Qiagen to create a global leader in personalised medicine for a value of $130 million ($95 million initial consideration plus earnouts of up to $35 million). For further information click here.